Technological advances in artificial intelligence (AI), automation, and robotics--once only dreamed of--are beginning to take shape and are promising to revolutionize healthcare and biotechnology. By 2021, AI alone could generate $6.7 billion in revenue from healthcare globally according to Frost & Sullivan. Some of the frontrunning scientists and physicians, who have worked toward AI and robotics advances for decades, spoke at the recent first annual Partnership for Artificial Intelligence, Automation, and Robotics in Healthcare (PATH) Summit, offering a distinct message: As these advanced technologies become integrated into healthcare and biotechnology there will be a significant change in the development and delivery of medicine resulting in improved outcomes, increased productivity, and wider dissemination. It is clear that doctors, health systems, and research institutes who don't embrace this new wave of technology will be left behind. PATH--a mission-driven, membership-based group launched by Jonathan Linkous, founding CEO of the American Telemedicine Association (ATA), and Mary Ann Liebert, publisher & CEO of Genetic Engineering & Biotechnology News (GEN), is dedicated to bringing together all stakeholders involved in the advancement of AI, automation, and robotics, to help guide policy related to its use and to promote its integration into health systems.